RayzeBio
Manufacturing · California, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
5505 Morehouse Dr Ste 300, San Diego, Ca...Phone Number
(619) 937-2754Website
www.rayzebio.comRevenue
$65.5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About RayzeBio
RayzeBio is a biotechnology company focused on improving outcomes for people with cancer by harnessing the power of targeted radioisotopes. With a focus on clinically validated solid tumor targets, RayzeBio is developing novel drug conjugates to deliver potent therapeutic radioisotopes such as Actinium-225, an alpha-emitter. The company is backed by a syndicate of sophisticated healthcare investors and was established in 2020.Explore more
RayzeBio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is RayzeBio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when RayzeBio launches new products
Congratulate Masked Content for being promoted to Masked Content at RayzeBio
Check if RayzeBio has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once RayzeBio has new funding data
RayzeBio, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if RayzeBio is spiking on competitors!
Earning: See what the market has to say on RayzeBio recently announced quarterly report
Click to see if RayzeBio had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to RayzeBio
Compare insights from companies similar to RayzeBio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
RayzeBio
$65.5M
201-500
Private
$418M
2020
ES
Eduardo SarretaVice President, Finance & Business Development
Company Profile Activity
Activity Insights
RayzeBio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
RayzeBio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about RayzeBio.
RayzeBio financials insights
Gather financial insights about RayzeBio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Series A
$45M
Series B
$105M
2021
Series C
$108M
2022
Series D
$160M
RayzeBio Tech Stack
A closer look at the technologies used by RayzeBio
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
RayzeBio News & Media
Philochem AG Announces the Licensing of Worldwide Rights to OncoACP3, a novel Radiopharmaceutical Therapeutic and Diagnostic Agent targeting Prostate Cancer, to RayzeBio, a Bristol-Myers Squibb Company, for a potential value of up to $1.35bn plus royalties
Philochem Licensing of OncoACP3 to RayzeBio for potential value of up to $1.35bn plus royaltiesvenBio Partners LLC Makes New $114.51 Million Investment in RayzeBio, Inc. (NASDAQ:RYZB)
venBio Partners LLC acquired a new stake in RayzeBio, Inc. (NASDAQ:RYZB - Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 5,158,162 shares of the company's stock, valued at approximately $114,511,
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding RayzeBio
Sign Up For FreeTo access detailed company insights
RayzeBio is a biotechnology company focused on improving outcomes for people with cancer by harnessing the power of targeted radioisotopes. With a focus on clinically validated solid tumor targets, RayzeBio is developing novel drug conjugates to deliver potent therapeutic radioisotopes such as Actinium-225, an alpha-emitter. The company is backed b... Read More
